Jordi Remon (@jordiremon) 's Twitter Profile
Jordi Remon

@jordiremon

Medical Oncologist - Thoracic tumors. Personalized treatment approches @EORTC

ID: 840695654120849408

calendar_today11-03-2017 22:47:18

420 Tweet

3,3K Takipçi

99 Takip Edilen

Jordi Remon (@jordiremon) 's Twitter Profile Photo

More data supports KRASi + IO in 1L NSCLC with mKRAS G12C. Today: olomorasib+pembro with high ORR regardless PDL1. (Adagrasib+pembro ⬆️activity in PDL1>50%) Hwvr, how comut (STK11/KEAP1) impact the efficacy of these combos? Should we add Chemo when exist comut at baseline?#ASCO25

More data supports KRASi + IO in 1L NSCLC with mKRAS G12C. Today: olomorasib+pembro with high ORR regardless PDL1. (Adagrasib+pembro ⬆️activity in PDL1>50%) Hwvr, how comut (STK11/KEAP1) impact the efficacy of these combos? Should we add Chemo when exist comut at baseline?#ASCO25